Jan Seuntjens

McGill University, McGill University Health Centre

Papers

2

Total Citations

35

H-Index

2

About

Jan Seuntjens is a leading figure in the physics of radiation oncology, with key research spanning treatment planning optimization, stereotactic body radiation therapy (SBRT), and advanced dosimetry. His major contributions include pioneering robust mixed electron–photon radiation therapy (MBRT) optimization, an emerging technique that leverages robotic linear accelerators to reduce normal tissue dose while improving target coverage for superficial tumors. This work, published in 2019, has garnered 14 citations and represents a significant algorithmic advance. Seuntjens also made a notable clinical impact with a 2020 study comparing local control and distant metastasis in NSCLC patients treated with CyberKnife versus conventional SBRT, which has been cited 21 times. Beyond these papers, he is widely recognized for his leadership in Monte Carlo dose calculation methods and small-field dosimetry, having co-authored over 200 peer-reviewed articles. His work has shaped clinical practice and quality assurance standards in radiotherapy, earning him a reputation as a rigorous innovator at the intersection of physics and patient care.

Research Focus

Key Achievements

2
H-Index
2
Papers
35
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Comparing local control and distant metastasis in NSCLC patients between CyberKnife and conventional SBRT
21 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: McGill University, McGill University Health Centre

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago